Trial begins for Spinal Modulation's pain management device

09/5/2013 | (Boston)

Spinal Modulation has begun patient enrollment in a clinical study to test whether its Axium neurostimulator device is safe and effective in treating patients with chronic lower limb pain. The trial will involve as many as 152 patients from up to 25 clinical sites in the U.S. St. Jude Medical has distribution rights for the technology, which could be added to its pain management portfolio if cleared in the U.S. and Europe.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC